219 related articles for article (PubMed ID: 8294859)
1. The mouse mammary tumor virus envelope gene product is required for superantigen presentation to T cells.
Golovkina TV; Chervonsky A; Prescott JA; Janeway CA; Ross SR
J Exp Med; 1994 Feb; 179(2):439-46. PubMed ID: 8294859
[TBL] [Abstract][Full Text] [Related]
2. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
Golovkina TV; Dudley JP; Ross SR
J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233
[TBL] [Abstract][Full Text] [Related]
3. Detection of retroviral superantigen and products of the envelope gene from endogenous mouse mammary tumor virus in B cells from BALB/c mice.
Lopez-Cepero M; Wang Y; Keydar I; Brandt-Carlson C; Butel JS; Lopez DM
Cell Immunol; 1995 Jul; 163(2):191-7. PubMed ID: 7606792
[TBL] [Abstract][Full Text] [Related]
4. In vivo effects of a recombinant vaccinia virus expressing a mouse mammary tumor virus superantigen.
Krummenacher C; Diggelmann H; Acha-Orbea H
J Virol; 1996 May; 70(5):3026-31. PubMed ID: 8627779
[TBL] [Abstract][Full Text] [Related]
5. Differences in the avidity of TCR interactions with a superantigenic ligand affect negative selection but do not allow positive selection.
Chervonsky AV; Golovkina TV; Ross SR; Janeway CA
J Immunol; 1995 Dec; 155(11):5115-23. PubMed ID: 7594520
[TBL] [Abstract][Full Text] [Related]
6. Diverse repertoire of the MHC class II-peptide complexes is required for presentation of viral superantigens.
Golovkina T; Agafonova Y; Kazansky D; Chervonsky A
J Immunol; 2001 Feb; 166(4):2244-50. PubMed ID: 11160278
[TBL] [Abstract][Full Text] [Related]
7. Mouse mammary tumor viruses with functional superantigen genes are selected during in vivo infection.
Golovkina TV; Dudley JP; Jaffe AB; Ross SR
Proc Natl Acad Sci U S A; 1995 May; 92(11):4828-32. PubMed ID: 7761408
[TBL] [Abstract][Full Text] [Related]
8. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
[TBL] [Abstract][Full Text] [Related]
9. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens.
Beutner U; Kraus E; Kitamura D; Rajewsky K; Huber BT
J Exp Med; 1994 May; 179(5):1457-66. PubMed ID: 8163931
[TBL] [Abstract][Full Text] [Related]
10. Human T cells respond to mouse mammary tumor virus-encoded superantigen: V beta restriction and conserved evolutionary features.
Labrecque N; McGrath H; Subramanyam M; Huber BT; Sékaly RP
J Exp Med; 1993 Jun; 177(6):1735-43. PubMed ID: 8388432
[TBL] [Abstract][Full Text] [Related]
11. Mouse mammary tumor virus superantigens require N-linked glycosylation for effective presentation to T cells.
McMahon CW; Bogatzki LY; Pullen AM
Virology; 1997 Feb; 228(2):161-70. PubMed ID: 9123822
[TBL] [Abstract][Full Text] [Related]
12. Role of dendritic cells in the immune response induced by mouse mammary tumor virus superantigen.
Baribaud F; Maillard I; Vacheron S; Brocker T; Diggelmann H; Acha-Orbea H
J Virol; 1999 Oct; 73(10):8403-10. PubMed ID: 10482591
[TBL] [Abstract][Full Text] [Related]
13. Strain-specific expression of spliced MMTV RNAs containing the superantigen gene.
Xu L; Wrona TJ; Dudley JP
Virology; 1997 Sep; 236(1):54-65. PubMed ID: 9299617
[TBL] [Abstract][Full Text] [Related]
14. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
Champagne E; Scarpellino L; Lane P; Acha-Orbea H
Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566
[TBL] [Abstract][Full Text] [Related]
15. Lack of MMTV superantigen presentation in MHC class II-deficient mice.
Beutner U; McLellan B; Kraus E; Huber BT
Cell Immunol; 1996 Mar; 168(2):141-7. PubMed ID: 8640859
[TBL] [Abstract][Full Text] [Related]
16. [Correlation between expression of antigen immunologically related to gp52 MMTV and transcription of homologous ENV MMTV DNA sequences in peripheral blood lymphocytes from breast cancer patients].
Lushnikova AA; Kriukova IN; Malivanova TF; Makhov PB; Polevaia EB
Mol Gen Mikrobiol Virusol; 1998; (3):33-6. PubMed ID: 9819826
[TBL] [Abstract][Full Text] [Related]
17. MHC class II hierarchy of superantigen presentation predicts efficiency of infection with mouse mammary tumor virus.
Held W; Waanders GA; MacDonald HR; Acha-Orbea H
Int Immunol; 1994 Sep; 6(9):1403-7. PubMed ID: 7819149
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection.
Golovkina TV; Chervonsky A; Dudley JP; Ross SR
Cell; 1992 May; 69(4):637-45. PubMed ID: 1316806
[TBL] [Abstract][Full Text] [Related]
19. Mouse mammary tumor virus-induced tumorigenesis in sag transgenic mice: a laboratory model of natural selection.
Golovkina TV; Prescott JA; Ross SR
J Virol; 1993 Dec; 67(12):7690-4. PubMed ID: 8230492
[TBL] [Abstract][Full Text] [Related]
20. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB).
Luther S; Shakhov AN; Xenarios I; Haga S; Imai S; Acha-Orbea H
Eur J Immunol; 1994 Aug; 24(8):1757-64. PubMed ID: 8056034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
